Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load Kinetics in Symptomatic Children, Adolescents, and Adults.

Adolescent Adult COVID-19 Child Humans Kinetics SARS-CoV-2 Viral Load Virus Shedding
COVID-19 SARS-CoV2 children viral shedding virus transmission

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
15 09 2021
Historique:
received: 03 03 2021
pubmed: 6 5 2021
medline: 24 9 2021
entrez: 5 5 2021
Statut: ppublish

Résumé

SARS-CoV-2 viral load (VL) can serve as a correlate for infectious virus presence and transmission. Viral shedding kinetics over the first week of illness for symptomatic children (n = 279), adolescents (n = 639), and adults (n = 7109) show VLs compatible with infectious virus presence, with slightly lower VL in children than adults.

Identifiants

DOI: 10.1093/cid/ciab396 PMID: 33949655 PMC: PMC8135785
pubmed: 33949655
pii: 6265276
doi: 10.1093/cid/ciab396
pmc: PMC8135785
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1384-e1386

Subventions

Organisme : Private HUG Foundation

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Mathilde Bellon (M)

Department of Molecular Medicine and Microbiology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.

Stephanie Baggio (S)

Division of Prison Health, Geneva University Hospitals, Geneva, Switzerland.
Office of Corrections, Department of Justice and Home Affairs of the Canton of Zurich, Zurich, Switzerland.

Frederique Jacquerioz Bausch (F)

Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland.
Primary Care Division, Geneva University Hospitals and, Geneva, Switzerland.

Hervé Spechbach (H)

Primary Care Division, Geneva University Hospitals and, Geneva, Switzerland.

Julien Salamun (J)

Primary Care Division, Geneva University Hospitals and, Geneva, Switzerland.

Camille Genecand (C)

Cantonal Health Service, General Directorate for Health, Geneva, Switzerland.

Aglae Tardin (A)

Cantonal Health Service, General Directorate for Health, Geneva, Switzerland.

Laurent Kaiser (L)

Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.

Arnaud G L'Huillier (AG)

Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.
Children's Hospital of Geneva, Geneva University Hospitals, Geneva, Switzerland.

Isabella Eckerle (I)

Department of Molecular Medicine and Microbiology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Severe Acute Respiratory Syndrome Coronavirus...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Severe Acute Respiratory Syndrome Coronavirus...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Severe Acute Respiratory Syndrome Coronavirus...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Severe Acute Respiratory Syndrome Coronavirus...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Severe Acute Respiratory Syndrome Coronavirus...
questionsmedicales.fr › Phénomènes chimiques › Phénomènes biochimiques › Cinétique › Severe Acute Respiratory Syndrome Coronavirus...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Severe Acute Respiratory Syndrome Coronavirus...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Charge virale › Severe Acute Respiratory Syndrome Coronavirus...
questionsmedicales.fr › Phénomènes physiologiques › Excrétion virale › Severe Acute Respiratory Syndrome Coronavirus...